Synthetic platelet-like particles developed for trauma care, addressing limitations in platelet transfusions.
A study published in Science Translational Medicine reveals a biomedical engineering innovation that could revolutionize trauma care and surgical practices. Chapman University's Andrew Lyon and Sanika Pandit, along with a multidisciplinary research team, developed synthetic platelet-like particles (PLPs) that integrate into the body's clotting pathways to stop hemorrhage. This breakthrough addresses the longstanding need for alternatives to platelet transfusions, which have storage constraints limiting their use in pre-hospital scenarios for acute trauma patients.
May 10, 2024
3 Articles